Director Karin Eastham not standing for re-election at Nektar's 2023 annual meeting

NEKTAR THERAPEUTICS

Karin Eastham informed Board she will not stand for re-election, completing term at 2023 annual meeting.
Departure is not due to any disagreement with the company on operations, policies, or practices.
Eastham served approximately five years as a director; no replacement announced.
Company thanks Eastham for her service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Karin Eastham

Director

NKTR · NEKTAR THERAPEUTICS

Filed: April 11, 2023, 7:59 PM ET

On April 6, 2023, Karin Eastham informed the Board of Directors (the “Board”) of Nektar Therapeutics (the “Company”) that she has elected not to stand for re-election and will complete her term on the Board at the conclusion of the Company’s 2023 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Karin Eastham departed as Director at NEKTAR THERAPEUTICS.

Action: elected not to stand for re-election
Role: Director

Exact text from the filing

On April 6, 2023, Karin Eastham informed the Board of Directors (the “Board”) of Nektar Therapeutics (the “Company”) that she has elected not to stand for re-election and will complete her term on the Board at the conclusion of the Company’s 2023 annual meeting of stockholders.

View on SEC.gov

NEKTAR THERAPEUTICS filing history →

Source: SEC EDGAR

accession 0001213900-23-028851

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.